Top Suppliers:I want be here


153004-31-0

153004-31-0 structure
153004-31-0 structure

Name (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfanyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
Synonyms ICI 182,780
(7α,17β)-7-{9-[(4,4,5,5,5-Pentafluoropentyl)sulfanyl]nonyl}estra-1,3,5(10)-triene-3,17-diol
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol
Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-, (7α,17β)-
(7R,8R,9S,13S,14S,17S)-13-Methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
Density 1.2±0.1 g/cm3
Boiling Point 622.1±55.0 °C at 760 mmHg
Molecular Formula C32H47F5O2S
Molecular Weight 590.771
Flash Point 330.0±31.5 °C
Exact Mass 590.321716
PSA 65.76000
LogP 10.06
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.513

~82%

153004-31-0 structure

153004-31-0

Literature: XI'AN LIBAND PHARMACEUTICAL CO., LTD. Patent: US2010/174101 A1, 2010 ; Location in patent: Page/Page column 4 ;

~%

153004-31-0 structure

153004-31-0

Literature: US2006/30552 A1, ; Page/Page column 25 ;

~%

153004-31-0 structure

153004-31-0

Literature: US2006/30552 A1, ; Page/Page column 26 ;